Corticosteroid prescription for asthma in adults: Modalities and pharmacology;Specificites pharmacologiques et modalites de prescription des corticoides dans l'asthme de l'adulte

Presse Medicale

Volumn 25, Issue 40, 1996, Pages 2025-2030

  Demoly, P ^a   Jaffuel, D ^a   Chung, K F ^b   Bousquet, J ^a   Michel, F B ^a   Godard, Ph ^a  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; DEXAMETHASONE; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; THEOPHYLLINE; GLUCOCORTICOID;

ASTHMA; DRUG EFFICACY; HUMAN; INHALATIONAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRESCRIPTION; REVIEW; ADULT; METABOLISM; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ADULT; ASTHMA; GLUCOCORTICOIDS; HUMANS;

EID: 0030461529     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Randolph TG, Rollins JP. Effect of cortisone in bronchial asthma. J Allergy Clin Immunol 1950 ; 21:228-95.
2. National Heart, Lung, and blood institute national asthma education program/expert panel report. Guidelines for the diagnosis and management of asthma. J Allergy Clin Immunol 1991 ; 88:425-534.
3. Barnes PJ. Greening AP. Crompton GK. Glucocorticoid resistance in asthma. Am J Respir Crit Care Med 1995 ; 152:3125-42.
4. McFadden ER. Dosages of corticosteroids in asthma. Am Rev Respir Dis 1993 : 147:1306-10.
5. Ogirala RG. Aldrich TK. Prezant DJ, Sinnel MJ. Enden JB. Williams MH. High-dose intramuscular triamcinolone in severe, chronic, life-threatenina asthma. N Engl J Med 1991 ; 324:585-9.
6. Moss RB. Alrernative pharmacotherupies for steroid-dependent asthma. Chest 1995 ; 107:817-25.
7. Lacronique J, Renon D. Georges D, Henry-Amur M, Marsac J. High-dose beclomethasone: oral steroid-sparing effect in severe asthmatic patients. Eur Respir J 1991 ; 4:807-12.
8. Noonan M, Chervinsky P, Busse W et al. Fluticasone propionate reduces oral prednisofic use while it improves asthma control and quality of life. Am J Respir Crit Care Med 1995 ; 152:1467-73.
9. Hummel S, Lehtonen. Group S. Comparison of oral-steroid sparing high-dose and low-dose inhaled steroid in maintenance treatment of severe asthma. Lancet 1992 ; 340:1483-7.
10. Wang JH, Trigg CJ, Devalia JL, Jordan S, Davies RJ. Effects of inhaled beclomethasone dipropionate on expression of proinflammatory cytokines and activated eosinophils in lhe bronchial epithelium of patients with mild asthma. J Allergy Clin Immunol 1994 ; 94:1025-34.
11. Bousquet J, Chanez P. Lacoste JY et al. Eosinophilic inflammation in asthma. N Engl J Med 1990 ; 323:1033-9.
12. Kharitonov SA, Yates D, Barnes PJ. Inhaled ghicocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1996 ; 153:454-7.
13. Skedinger M, Halldén G, Lundahl J, Hed J, Zetterström O. Eosinophil activity reflects clinical status in patients with asthma before and during a prednisolone course. Ann Allergy 1995 ; 75:2305-7.
14. Wever AMJ. Wever-Hess J. Hensgens HKSJ, Hermans J. Serum eosinophil cationic protein (ECP) in chronic asthma. Relationship to spirometry, flow-volume curves. PC20, and exacerbations. Respir Med 1994 ; 88:613-21.
15. Fahy JV, Liu J, Wong H, Boushey HA. Analysis of cellular and biochemical constituents of induced sputum after allergen challenge: a method for studying allergic airway inflammation. J Allergy Clin Immunol 1994 ; 93:1031-9.
16. Haahtela T, Järvinen M, Kava T et al. Comparison of a β2-agonist. terbulaline, with an inhaled corticosteroid. budesonide. in newly detected asthma. N Engl J Med 1991 ; 325:388-92.
17. Hihihtela T, Jarvinen M, Kava T et al. Effects of reducing or discontinuing inhalcd budesonide in patients with mild asthma. N Engl J Med 1994 ; 331:700-5.
18. Selroos O. Pietinalho A. Löfroos AB, Riska H. Effect of early versus late intervention with inhaled corticosteroids in asthma. Chest 1995 ; 108:1228-34.
19. Boc J, Rosenhall L. Alton M et al. Comparison of dose-response effects of inhaled beclomethasone dipropionate and budesonide in the management of asthma. Allergy 1989 ; 44.349-55.
20. Dahl R, Lundhack B, Malo J et al. A dose ranging sludy of flutieasone propionate in adult patients with moderate asthma. Chest 1993 ; 104;1352-8.
21. Vathenen AS, Knox AJ, Wisniewski A, Tattersfield AE. Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma. Am Rev Respir Dis 1941 ; 143:1317-21.
22. Juniper EF. Kline PA, Vanzieleghem MA. Hargreave FE. Reduction of budesonide after a year of inereased use: a randomized controlled trial study to evaluate whether improvements in airway responsiveness and clinical asthma are maintained. J Allergy Clin Immunol 1991 ; 87:483-9.
23. Boulet LP. Giguèrc MC, Milol J, Brown J. Effects of long-term use of high-dose inhaled steroids on bone density and calcium metabolism, J Allergy Clin Immunol 1994 ; 94:796-803.
24. Toogood JH, Baskerville J. Markov AE et al. Bone mineral density and the risk of fracture in patients receiving long term inhaled steroid for asthma. J Allergy Clin Immunol 1995 ; 96: 157-66.
25. Roy A. Leblanc C, Paquette L et al. Skin bruising in asthmatics subjects treated with high doses of inhaled steroids: frequency and associated with adrenal function. Eur Respir J 1996; 9:226-31.
26. Zwaan CM, Odink RJH. Delamarre-Van de Waal HA, Dankaert-Roelse JE. Acute adrenal insufliciency after discontinuation of inhaled corticosteroid therapy. Lancet 1992 ; 340:1289-90.
27. Abuekleish F, Kirkpatrick JNP, Russel G. Posterior subcapsular cataract and inhaled corticosteroid therapy. Thorax 1995 ; 50:674-6.
28. Woolcock A, Lundcack B, Tinydal N. Jacques LA. Comparison of addition of samleterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996 ; 153:1481-8.
29. Busse WW, Middleto K. Storms W et al Corticosteroid-sparing effect of azelastine in the management of broehial asthma. Am J Respir Crit Cate Med 1996 ; 153:112-7.
30. Malo JL. Cartier A, Merlantl N et al. Four-times-a-day dosing frequency is better than a twice-a-day regimen in subjects requiring a high-dose inhaled steroid budesonide, to control moderate to severe asthma. Am Rev Respir Dis 1989 ; 140:624-8.
31. Weiner P, Weiner M, Azgad Y. Long term comparison of single versus twice daily administration of inhaled budesonide in moderate asthma. Thorax 1995 ; 50:1270-3.
32. Dompeling E. Van Girunsven PM. Van Schayck CP, Folgering H, Molema J, Van Weel C. Treatment with inhaled steroids in asthma and chronic bronchitis: long-term compliance and inhaler technique. Family Prdctice 1992 ; 9:161-6.